What we are exposed to in early life can affect our risk of developing cancer later in life. What exposures matter in early life are still not fully clear, but front-runners include diet, lifestyle, the environment and the bugs that live in our gut.
We know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose weight and get enough sleep. But what if much of what causes cancer has already happened in our early years, or worse still, before we were born. A recent study from Brigham and Women’s Hospital and Harvard University says that may be the case, especially in cancers that happen before the age of 50 (early-onset cancers).
The most important finding in this study, published in Nature Reviews Clinical Oncology, is that people born after 1990 are more likely to develop cancer before the age of 50 than people born, for example, in 1970. Meaning that young people will be more heavily burdened by cancer than generations gone by, with the knock-on effects on healthcare, economics and families. This review of cancer trends looks at how these factors might be affecting early-onset cancers.
When looking at large numbers of people, researchers can see that dietary and lifestyle habits are formed early in life. This is seen in obesity where obese children are more likely to become obese adults. As obesity is a known risk factor for cancer, it follows that those adults are likely to develop cancer at an earlier age, possibly because they have been exposed to the risk factor for a longer time.
Of course, some of these early-onset cancers are detected through better screening programmes and earlier diagnosis, which contributes to increased numbers of new cancers diagnosed annually, worldwide. But that is not the whole story.
Early-onset cancers have different genetic signatures compared with late-onset cancers and are more likely to have spread than cancers diagnosed in later life. This means that those cancers may need different types of treatment and a more personalised approach that is tailored to the patient’s age at the time the cancer developed.
The Brigham study looked at 14 cancers and found that the genetic makeup of the cancer and the aggression and growth of the cancer was different in patients who developed it before the age of 50 compared with those who developed the same cancer after the age of 50.
This seemed to be more prominent in several types of gut cancers (colorectal, pancreatic, stomach). One possible reason for this relates to our diet and microbiome.
Gut bacteria are altered by high-sugar diets, antibiotics and breastfeeding. And as patterns of these things change in society over time, so do the bacteria in our gut. This might support the implementation of sugar taxes as recommended by the World Health Organization.
If our healthy cells are programmed in the womb, then so might the cells that go on to cause cancer. Maternal diet, obesity and environmental exposures, such as air pollution and pesticides, are known to increase the risk of chronic diseases and cancers.
Conversely, severe restrictions on food intake in pregnancy, as seen in famine, increase the risk of breast cancer in offspring. Both of these findings would have different implications for societal approaches to reducing cancer risk.
As a haematologist, I take care of patients with multiple myeloma, which is an incurable blood cancer that usually affects patients over the age of 70. In recent years, there has been an increased number of younger people diagnosed with this cancer worldwide, which is only partly explained by better screening. This study flags obesity as an important risk factor for early-onset disease, but clearly, there are other risk factors yet to be uncovered.
Understanding what makes early-onset cancers tick, what exposures really matter and what can be done to prevent them are some of the first steps to developing prevention strategies for future generations.
This article was originally published on The Conversation on 20 September 2022.
Professor Siobhan Glavey is Chair and Professor in the Department of Pathology at RCSI. Her focus is to build on RCSI's international track record in pathology teaching and research by advancing the university's use of new educational technologies.
RCSI is committed to achieving a better and more sustainable future through the UN Sustainable Development Goals.